September 11, 2025 01:00 PM MST
Potential Application of the Cannabinoids as Antivirals
Dr. Mark T. Hamann is the Charles and Carol Cooper/SmartState Endowed Chair of Drug Discovery at the Medical University of South Carolina (MUSC), serving in the Colleges of Pharmacy and Medicine. He holds affiliate appointments with the University of Maryland’s Institute of Marine and […]
14 August, 2025 1 PM MST
Minor Cannabinoids for Pain and Emerging Concerns with Unregulated Cannabinoids
https://youtu.be/bdRiQXXwOzQ
Dr. Kent Vrana is the Elliot S. Vesell Professor of Pharmacology (Chair Emeritus) in the Department of Molecular and Precision Medicine at the Penn State College of Medicine. He has a BS from the University of Iowa and a PhD from […]
10 July, 2025, 1 PM MST
Understanding Young Adults’ Cannabis Use and Craving in Naturalistic Settings: Insights from Ecological Momentary Assessment
Dr. Rachel Tomko is an Associate Professor in the Addiction Sciences Division at MUSC’s Department of Psychiatry and Behavioral Sciences and a licensed clinical psychologist. Her research focuses on how individual and sex-related factors influence cannabis […]
Systematically Testing the Evidence on Marijuana (STEM): Bridging the science of cannabis health effects and clinical practice
June 12, 2025, 1:00 PM MST
Devan Kansagara MD, MCR is a Professor of Medicine at Oregon Health and Science University. He practices and teaches primary care and hospital- based internal medicine in the VA Portland Health Care System. His […]
Effects of isolated cannabinoids and endocannabinoids on emotional behavior in rodents
May 8, 2025 1:00 PM MST
Dan is currently an Assistant Professor at Lovelace Biomedical Research Institute (LBRI) in Albuquerque, New Mexico. He started this position in June 2020 after completing his PhD at Illinois State University and a postdoctoral fellowship at the University of Maryland […]
Preclinical modeling of spontaneous Δ-9-THC withdrawal symptoms in mice: sleep, dopamine, and behavioral maladaptations
April 10th, 1:00PM MST
Dr. Kesner is the Chief of the Unit on Motivation and Arousal at National Institute on Alcohol Abuse and Alcoholism (NIAAA). The mission of his lab is to use systems neuroscience approaches to understand how brain systems controlling motivated […]
Neural mechanisms of risk for problem-level cannabis use among emerging adults
Dr. Lichenstein is a licensed clinical psychologist, an Assistant Professor of Psychiatry, and Assistant Director of the Yale Imaging and Psychopharmacology Lab at Yale School of Medicine. She received her BA in Psychology from Bard College (2008), and her PhD in Clinical Psychology from the […]
January 9th at 1:00PM MST
Thoughtful approaches to chronic pain and cannabis research
Dr. Kevin Boehnke is an Assistant Professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. Kevin received his doctorate from the University of Michigan School of Public Health in Environmental Health Sciences in 2017. He is also a […]
December 12th at 1:00PM MST
Cannabis-related psychiatric disorders
Dr. David Gorelick earned his bachelor degree in psychology from Cornell University and his medical degree and PhD in pharmacology from Albert Einstein College of Medicine. After completing his psychiatry residency at UCLA, he remained on the faculty until 1989, when he moved to the NIDA Intramural Research […]
10 October 2024, 1:00PM MST
Cannabis and driving: knowns and known unknowns
Dr. Pearlson’s medical training was at the University of Newcastle upon Tyne in England. Following internship he completed a graduate degree in philosophy at Columbia University in New York and was then successively a resident, postdoctoral fellow and faculty member at Johns Hopkins […]
12 September 2024, 1:00PM MST
Chronic and Acute Effects of High Potency Cannabis Flower and Concentrates on Cognition
Dr. Carrie Cuttler received her Ph.D. in Psychology at the University of British Columbia (UBC) and subsequently conducted a post-doctoral fellowship in the Department of Psychiatry at UBC. She is currently an Associate Professor and Director of […]
Interactions of Delta-9 Tetrahydrocannabinol
July 11, 2024, 1:00 PM
Dr. Weerts is a Professor in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine, and core faculty in the preclinical Division of Behavioral Biology (DBB) the Behavioral Pharmacology Research Unit (BPRU) for human clinical and laboratory research. She has […]
Limonene, THC, Herbal Synergy and the Entourage Effect
June 13, 2024, 1:00PM MT
Ethan Russo, MD, is a board-certified child and adult neurologist(1987), psychopharmacologist, and Founder/CEO of CReDO Science. He is also Chief Medical Officer to Andira Pharmaceuticals, Senior Medical Advisor to Canurta, and Medical Director of Breeder’s Best. He was Director of R&D for the […]
How the CB1 cannabinoid receptor communicates within the cell via associated proteins
April 11, 2024, 1 PM MST
Dr. Allyn C. Howlett is a Professor of Physiology and Pharmacology at Wake Forest University School of Medicine, Assistant Dean of WFU Graduate School Biomedical Programs, and Director of the Office of Postdoctoral Education. Dr. Howlett is an […]
From Seed to Synapse: Modeling the Long-Term
Impacts of Developmental Cannabis Exposure
March 14, 2024, 1 PM MST
Dr. Ryan McLaughlin is an Associate Professor in the Department of Integrative Physiology and Neuroscience at Washington State University (WSU). The overarching goal of Dr. McLaughlin’s research program is to determine how endogenous and exogenous cannabinoids affect the brain […]
The therapeutic promise of non-addicting cannabinoid analgesics
February 2024
Andrea G. Hohmann is a Linda and Jack Gill Chair of Biomolecular Science and Professor of Psychological and Brain Sciences at Indiana University Bloomington. Dr. Hohmann received her Ph.D. from Brown University and completed postdoctoral training at NIMH and NIDCR in functional neuroanatomy and pain and neurosensory […]